PA8513301A1 - Inhibidor del intercambiador de sodio-hidrògeno de tipo 1 - Google Patents

Inhibidor del intercambiador de sodio-hidrògeno de tipo 1

Info

Publication number
PA8513301A1
PA8513301A1 PA20018513301A PA8513301A PA8513301A1 PA 8513301 A1 PA8513301 A1 PA 8513301A1 PA 20018513301 A PA20018513301 A PA 20018513301A PA 8513301 A PA8513301 A PA 8513301A PA 8513301 A1 PA8513301 A1 PA 8513301A1
Authority
PA
Panama
Prior art keywords
inhibitor
sodium
type
hydrogen exchanger
nhe
Prior art date
Application number
PA20018513301A
Other languages
English (en)
Inventor
Weichao George Chen
Eric David Cox
Angel Guzman-Perez
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8513301A1 publication Critical patent/PA8513301A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN INHIBIDOR DE NHE-1, METODOS PARA UTILIZAR EL INHIBIDOR DE NHE-1 Y COMPOSICIONES FARMACEUTICAS QUE CONTIENEN EL INHIBIDOR DE NHE-1. EL INHIBIDOR DE NHE-1 ES UTIL PARA LA REDUCCION DE LAS LESIONES TISULARES RESULTANTES DE LA ISQUEMIA DE LOS TEJIDOS.
PA20018513301A 2000-04-28 2001-03-12 Inhibidor del intercambiador de sodio-hidrògeno de tipo 1 PA8513301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
PA8513301A1 true PA8513301A1 (es) 2003-09-05

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20018513301A PA8513301A1 (es) 2000-04-28 2001-03-12 Inhibidor del intercambiador de sodio-hidrògeno de tipo 1

Country Status (40)

Country Link
EP (1) EP1276737A1 (es)
JP (1) JP2003531900A (es)
KR (1) KR20020093079A (es)
CN (1) CN1225466C (es)
AP (1) AP2002002651A0 (es)
AR (1) AR028375A1 (es)
AU (1) AU2001235896A1 (es)
BG (1) BG107139A (es)
BR (1) BR0110268A (es)
CA (1) CA2407535A1 (es)
CO (1) CO5221125A1 (es)
CR (1) CR6797A (es)
CZ (1) CZ20023408A3 (es)
DZ (1) DZ3310A1 (es)
EA (1) EA004882B1 (es)
EE (1) EE200200615A (es)
GT (1) GT200100064A (es)
HN (1) HN2001000042A (es)
HR (1) HRP20020851A2 (es)
HU (1) HUP0300651A2 (es)
IL (1) IL152075A0 (es)
IS (2) IS6567A (es)
MA (1) MA26897A1 (es)
MX (1) MXPA02010600A (es)
MY (1) MY133842A (es)
NO (1) NO20025132L (es)
NZ (1) NZ521348A (es)
OA (1) OA12256A (es)
PA (1) PA8513301A1 (es)
PE (1) PE20011270A1 (es)
PL (1) PL357765A1 (es)
SK (1) SK14872002A3 (es)
SV (1) SV2002000418A (es)
TN (1) TNSN01065A1 (es)
TR (1) TR200202439T2 (es)
UA (1) UA73348C2 (es)
UY (1) UY26680A1 (es)
WO (1) WO2001083470A1 (es)
YU (1) YU79602A (es)
ZA (1) ZA200208605B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL156220A0 (en) * 2001-01-31 2003-12-23 Pfizer Prod Inc Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
AU2002337460A1 (en) * 2001-12-19 2003-06-30 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
CA2483927A1 (en) * 2002-05-02 2003-11-13 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
US7550480B2 (en) * 2003-02-14 2009-06-23 Smithkline Beecham Corporation Compounds
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA003603B1 (ru) * 1998-02-27 2003-06-26 Пфайзер Продактс Инк. N-[(замещенное пятичленное ди- или триазадиненасыщенное кольцо) карбонил] гуанидиновые производные для лечения ишемии

Also Published As

Publication number Publication date
EA200201023A1 (ru) 2003-02-27
JP2003531900A (ja) 2003-10-28
TNSN01065A1 (fr) 2005-11-10
EP1276737A1 (en) 2003-01-22
EE200200615A (et) 2004-04-15
CN1426404A (zh) 2003-06-25
CO5221125A1 (es) 2002-11-28
KR20020093079A (ko) 2002-12-12
ZA200208605B (en) 2003-10-24
IS6567A (is) 2002-09-24
NO20025132L (no) 2002-12-12
NO20025132D0 (no) 2002-10-25
UY26680A1 (es) 2001-12-28
TR200202439T2 (tr) 2003-02-21
CN1225466C (zh) 2005-11-02
HRP20020851A2 (en) 2005-02-28
WO2001083470A1 (en) 2001-11-08
IS6588A (is) 2002-10-21
IL152075A0 (en) 2003-05-29
SV2002000418A (es) 2002-07-03
HN2001000042A (es) 2001-07-09
AU2001235896A1 (en) 2001-11-12
PE20011270A1 (es) 2001-12-12
MXPA02010600A (es) 2003-03-10
PL357765A1 (en) 2004-07-26
UA73348C2 (en) 2005-07-15
MA26897A1 (fr) 2004-12-20
YU79602A (en) 2006-05-25
OA12256A (en) 2003-11-06
CA2407535A1 (en) 2001-11-08
BR0110268A (pt) 2003-12-30
AP2002002651A0 (en) 2002-12-31
NZ521348A (en) 2004-09-24
AR028375A1 (es) 2003-05-07
CZ20023408A3 (cs) 2004-01-14
HUP0300651A2 (hu) 2003-07-28
CR6797A (es) 2004-05-17
SK14872002A3 (sk) 2004-03-02
EA004882B1 (ru) 2004-08-26
DZ3310A1 (fr) 2001-11-07
BG107139A (bg) 2003-07-31
GT200100064A (es) 2002-03-22
MY133842A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
ES2195970T3 (es) L-ribavirina y usos de la misma.
ES2145638T3 (es) Nuevos compuestos azoicos, utilizacion para tincion, composiciones que los contienen y procedimientos de tincion.
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
BR9913745A (pt) Cetonas de piridina úteis como herbicidas
ES2191183T3 (es) Derivados 6,6- o 6,7-biciclicos que contienen pirido o pirimido sustituidos.
ECSP055747A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
BR0109542A (pt) Derivados de imidazopirina alquilados
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
PA8513301A1 (es) Inhibidor del intercambiador de sodio-hidrògeno de tipo 1
AR030537A1 (es) Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos
PA8466101A1 (es) Agentes terapeuticos
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
GT199900113A (es) Inhibidores de las fkbp.
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2164151T3 (es) N-(indol-2-carbonil)glicinamidas sustituidas y derivados como inhibidores de la glucogeno fosforilasa.
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
MX9306178A (es) Bencimidazoles medicamentos que contienen estos compuestos yprocedimientos para su preparacion.
AR006675A1 (es) 4-benzoilisotiazoles herbicidas, procedimiento para obtenerlas, las composiciones herbicidas que las contienen y el procedimiento de aplicacionde dichos compuestos.
AR025797A1 (es) Quinazolinonas